B. Riley Securities Initiates Coverage On Foghorn Therapeutics with Buy Rating, Announces Price Target of $10
Benzinga Newsdesk 1 year ago
NewsPrice TargetInitiationAnalyst Ratings
B. Riley Securities analyst Kalpit Patel initiates coverage on Foghorn Therapeutics (NASDAQ:FHTX) with a Buy rating and announces Price Target of $10.
B. Riley Securities analyst Kalpit Patel initiates coverage on Foghorn Therapeutics (NASDAQ:FHTX) with a Buy rating and announces Price Target of $10.